Publication Name	World Journal of Clinical Cases
Manuscript ID	75464
Country	China

Received	2022-02-07 09:29
Peer-Review Started	2022-02-07 09:29
To Make the First Decision
Return for Revision	2022-03-22 03:29
Revised	2022-03-26 01:52
Second Decision	2022-04-06 02:11
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-04-09 18:25
Articles in Press	2022-04-09 18:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-05-25 09:02
Publish the Manuscript Online	2022-06-09 07:17

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medical Ethics
Manuscript Type	Minireviews
Article Title	Ethical review of off-label drugs during the COVID-19 pandemic
Manuscript Source	Unsolicited Manuscript
All Author List	Qiu-Yu Li, Ye Lv, Zhuo-Yu An, Ni-Ni Dai, Xue Hong, Yu Zhang and Li-Jun Liang
ORCID	Author(s) ORCID Number Qiu-Yu Li http://orcid.org/0000-0002-8707-5229 Ye Lv http://orcid.org/0000-0001-7920-074X Zhuo-Yu An http://orcid.org/0000-0003-0976-160X Ni-Ni Dai http://orcid.org/0000-0003-0429-1645 Yu Zhang http://orcid.org/0000-0002-9734-4779 Li-Jun Liang http://orcid.org/0000-0003-0919-246X
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81900641 Peking University Health Center for Combating the Pandemic Programs BMU 2021MX020 Peking University Health Center for Combating the Pandemic Programs BMU 2022MX008
Corresponding Author	Qiu-Yu Li, MD, Doctor, Doctor, Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China. liqiuyu00@bjmu.edu.cn
Key Words	COVID-19; Off-label; Chloroquine; Hydroxychloroquine
Core Tip	High-quality scientific research is very important in the attempt to effectively control the coronavirus disease 2019 epidemic and ensure people’s life health and safety. Chloroquine and hydroxychloroquine have received much attention.
Publish Date	2022-06-09 07:17
Citation	Li QY, Lv Y, An ZY, Dai NN, Hong X, Zhang Y, Liang LJ. Ethical review of off-label drugs during the COVID-19 pandemic. World J Clin Cases 2022; 10(17): 5541-5550
URL	https://www.wjgnet.com/2307-8960/full/v10/i17/5541.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i17.5541

Full Article (PDF)	WJCC-10-5541.pdf
Full Article (Word)	WJCC-10-5541.docx
Manuscript File	75464_Auto_Edited-YJM.docx
Answering Reviewers	75464-Answering reviewers.pdf
Audio Core Tip	75464-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	75464-Conflict-of-interest statement.pdf
Copyright License Agreement	75464-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	75464-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	75464-Language certificate.pdf
Peer-review Report	75464-Peer-review(s).pdf
Scientific Editor Work List	75464-Scientific editor work list.pdf
CrossCheck Report	75464-CrossCheck report.pdf